SIDT2 RNA transporter promotes lung and gastrointestinal tumor development
Journal Title
iScience
Publication Type
Journal Article
Abstract
RNautophagy is a newly described type of selective autophagy whereby cellular RNAs are transported into lysosomes for degradation. This process involves the transmembrane protein SIDT2, which transports double-stranded RNA (dsRNA) across the endolysosomal membrane. We previously demonstrated that SIDT2 is a transcriptional target of p53, but its role in tumorigenesis, if any, is unclear. Unexpectedly, we show here that Sidt2(-/-) mice with concurrent oncogenic Kras(G12D) activation develop significantly fewer tumors than littermate controls in a mouse model of lung adenocarcinoma. Consistent with this observation, loss of SIDT2 also leads to enhanced survival and delayed tumor development in an Apc(min/+) mouse model of intestinal cancer. Within the intestine, Apc(min/+);Sidt2(-/-) mice display accumulation of dsRNA in association with increased phosphorylation of eIF2alpha and JNK as well as elevated rates of apoptosis. Taken together, our data demonstrate a role for SIDT2, and by extension RNautophagy, in promoting tumor development.
Publisher
Elsevier
Research Division(s)
Inflammation; Personalised Oncology
PubMed ID
31546103
Open Access at Publisher's Site
https://doi.org/10.1016/j.isci.2019.09.009
NHMRC Grants
NHMRC/1064591
Terms of Use/Rights Notice
Refer to copyright notice on published article.


Creation Date: 2019-10-23 02:22:53
Last Modified: 2019-10-23 02:42:46
An error has occurred. This application may no longer respond until reloaded. Reload 🗙